Metraipolis › archive › dc_5dba0953ccce

Clinical improvement of photophobia with galcanezumab in episodic and chronic migraine — Europe PMC PMID:42306626

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42306626
DOI
10.3389/fneur.2026.1792472
License (as archived)
solo-consultazione
Archived
2026-11-01T01:34:05.677Z
SHA-256 of the archived text
6803cc2bc468c3afae7648ff676bb90cd030f9b5645d7d477005a6cbff7bc9c6
Stable URL of this page
https://metraipolis.com/documento/dc_5dba0953ccce

How to cite

Clinical improvement of photophobia with galcanezumab in episodic and chronic migraine — Europe PMC PMID:42306626 — Europe PMC (en), https://europepmc.org/article/MED/42306626 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5dba0953ccce (Metraipolis archive dc_5dba0953ccce, sha256 6803cc2bc468c3afae7648ff676bb90cd030f9b5645d7d477005a6cbff7bc9c6)
BibTeX
@misc{dc5dba0953ccce,
  title = {Clinical improvement of photophobia with galcanezumab in episodic and chronic migraine — Europe PMC PMID:42306626},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42306626},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5dba0953ccce; sha256 6803cc2bc468c3afae7648ff676bb90cd030f9b5645d7d477005a6cbff7bc9c6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42306626. Agents can read the archived copy with the MCP tool read_document.